BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 2602645)

  • 1. Mediastinal Hodgkin's disease. Significance of mediastinal involvement in early stage Hodgkin's disease.
    Mauch P; Hellman S
    Hematol Oncol; 1984; 2(1):69-72. PubMed ID: 6547403
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of MOPP chemotherapy in early stage Hodgkin's disease.
    Mauch P; Hellman S
    Hematol Oncol; 1984; 2(1):66-9. PubMed ID: 6376318
    [No Abstract]   [Full Text] [Related]  

  • 3. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
    De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
    Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
    Casini M; Pianezze G; Fabris P; Cemin S; Coser P
    Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
    Fuller LM; Hagemeister FB
    Recent Results Cancer Res; 1989; 117():197-204. PubMed ID: 2602645
    [No Abstract]   [Full Text] [Related]  

  • 7. Current management of Hodgkin's disease.
    Behrens BC; Young RC; DeVita VT
    Drugs; 1985 Oct; 30(4):355-67. PubMed ID: 3905335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease: controversies and challenges for the future.
    Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
    Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined-modality therapy for the treatment of Hodgkin's disease.
    Hoppe RT
    Front Radiat Ther Oncol; 1992; 26():172-80. PubMed ID: 1511919
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy in the treatment of Hodgkin's disease.
    Canellos GP; Come SE; Skarin AT
    Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
    Longo DL; DeVita VT
    Important Adv Oncol; 1992; ():155-65. PubMed ID: 1582671
    [No Abstract]   [Full Text] [Related]  

  • 12. Early-stage Hodgkin's disease: current approaches to treatment.
    Rusthoven JJ; MacKenzie R
    Can Med Assoc J; 1985 Aug; 133(3):193-8. PubMed ID: 3893668
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.